People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Nasal steroids provided the most significant benefit, especially when compared to montelukast. Nasal antihistamines also ...

In people prone to allergies, exposure to pollen and allergens triggers the release of histamine—a chemical responsible for ...

A nasal rinse is a common practice to clear nasal passages, especially during cold, flu, and allergy seasons. Here's who can ...

Yes, allergies can make you feel tired. Fatigue is a common allergy symptom, and it’s caused by factors like inflammation or ...

Eurofins CDMO Amatsiaquitaine S.A.S., the GMP manufacturer, to support Polyrizon in future commercialization effortsRaanana, Israel, Jan. 23, ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.